January marked a flurry of resignations among the highest ranks of Kodak leadership. On Jan. 7, the company announced that Patricia F. Russo had resigned as president and COO to become CEO of Lucent Technologies. Less than a week earlier, Kodak senior
January marked a flurry of resignations among the highest ranks of Kodak leadership. On Jan. 7, the company announced that Patricia F. Russo had resigned as president and COO to become CEO of Lucent Technologies. Less than a week earlier, Kodak senior vice president J. Michael McQuade said he would step down as president of Kodak's Health Imaging unit to become a vice president of 3M's medical products division. Kodak chairman of the board and CEO Daniel A. Carp has assumed the responsibilities of Kodak president and COO. Candy M. Obourn, as COO of the company's Health Imaging unit, has assumed McQuade's duties. The search has begun for a new president of the Health Imaging unit.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.